MARKET

BDTX

BDTX

BLACK DIAMOND THERAPEUTICS, INC.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

24.95
-0.45
-1.77%
Closed 16:00 03/31 EDT
OPEN
25.30
PREV CLOSE
25.40
HIGH
25.74
LOW
23.69
VOLUME
176.30K
TURNOVER
--
52 WEEK HIGH
41.79
52 WEEK LOW
17.63
MARKET CAP
895.97M
P/E (TTM)
-23.0954
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BDTX stock price target is 48.50 with a high estimate of 50.00 and a low estimate of 47.00.

EPS

BDTX News

More
  • Black Diamond Therapeutics reports Q4 results
  • seekingalpha · 03/24 16:34
  • The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
  • Benzinga · 03/12 11:37
  • The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
  • Benzinga · 03/11 12:05
  • The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index
  • Benzinga · 03/10 13:19

Industry

Biotechnology & Medical Research
-0.49%
Pharmaceuticals & Medical Research
-0.25%

Hot Stocks

Symbol
Price
%Change

About BDTX

Black Diamond Therapeutics, Inc. is a precision oncology medicine company. The Company’s technology platform, Mutation-Allostery-Pharmacology (MAP) platform is designed to allow it to analyze population-level genetic sequencing data to identify oncogenic mutations that promote cancer across tumor types, group these mutations into families and develop a single small molecule therapy in a tumor-agnostic manner that targets a specific family of mutations. The Company has designed its lead product candidate, BDTX-189, to block the function of an undrugged family of oncogenic proteins defined by mutations which occur across a range of tumor types, and which affect both the epidermal growth factor receptor (EGFR) and the tyrosine-protein kinase ErbB-2, or HER2.
More

Webull offers kinds of Black Diamond Therapeutics Inc stock information, including NASDAQ:BDTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BDTX stock news, and many more online research tools to help you make informed decisions.